| Lightcalls.com |
|
|
![]() |
Fat substitutes will ensue and go,...Fat substitutes will ensue and go, but the plain fact is that there's no substitute for a responsible lifestyle which emphasizes a worthy diet. That said, we should remember that eating should be merriment not a chore or a torment. And the bodily substance who said that a special provender shouldn't be used as a reward for reaching life/family milestones and for achieving personal and career objectives should be hasten out on the next train to fuddy-duddy-land. viands is an intimate part of our lives. it helped us survive when sabre-toothed tigers were padding around our caves. It's also an important part of our principally sacred religious rites and ceremonial observances, and figures prominently in the world's most numerous critical international-business deals and diplomatic negotiations. Eating better - not depriving yourself That also said, too to a great degree food in the diet - or of certain constituents in it, such as fat - can most numerous definitely be bad. But "dieting," in the strictest intellect should be approached with caution. Crash-dieting, in fact, rarely clears the problem it is intended to address," say Susan C Wooley Phd and David M Garner, PhD in an article which appeared in the Journal of the American Dietetic Association in October 1991 "[In truth] it may well exacerbate the question by draining away emotional and physical resources." "Additionally, it is now widely agreed that obesity treatment is, in general ineffective: in many instances, it is destructive, the authors add. "It may provide patients with failure experiences, show up them to professionals who restrain them in low regard, cause them to view themselves as deviant and flawed and confuse their perceptions of crave food and satiety." Nevertheless, the race to figure disclosed the genetics of weight los is in succession That's nowhere more true than in our nation's science laboratories, where the effort to bring out a [compound] that will alleviate obesity has become single of the most prominent [] I research races of the 1990s" according to the Summer 1996 issue of Forefront, a newsletter enjoin out by Purdue University's Office of Agricultural Research Programs. This latest scientific sprint in good earnest began in 1994, when Rockefeller University announced that it had "bested" several other research institutions by way of locating a gene that assumes to control obesity. The so-called ob gene - ob for obesity - became the in the greatest degree famous in the human genome. In fact, from head to foot 1995, the photo of the fat mouse nearest to the thin mouse was carried at nearly every media outlet in the nation," Forefront added, and the story ran in Newsweek, Time, The Wall way Journal, etc. All of the latest scientific studies - including those which appeared in solitary abode; squalid Nature, and Science - reported that the gene partly works from producing a protein, called leptin, undivided which causes a hormonal replication in the brain that says to us "I've had enough to eat!" Purdue biochemist, KiHan Kim, PhD has shown that fat production was slowed by the agency of leptin, as well. "My thinking is that it works by dint of inhibiting the synthesis of fat in fat confined apartments and increasing the burning of fat in muscle cells" says Kim. "It works at an enzymatic, subcellular level" The gene apparently causes solitary abode; squalids to produce leptin suppresses a gene that manufactures an enzyme called acetyl-CoA carboxylase, or ACC, which is be in want ofed for fat production. Rather suspect ways to beat public fat have been gaining moment since 1990. Although no substitute for fit diet, fat-substitutes are all the rage It was six years ago when Monsanto's Nutrasweet Company released its fat-substitute, Simplesse," a concoction made by dint of "cooking and blending egg white and milk protein to create a creamy, rich fluid with the constitution of fat," says a company pamphlet issued in 1990. In the same year, Kraft General forages petitioned the FDA (U.S. cheer and Drug Administration) for approval of its have a title to fat substitute, Trailblazer, which, like Monsanto's performance was made from egg and milk protein steped to mimic the `mouth feel' of fat," said FDA Consumer in December of that year. In 1990 the developer of however another fake fat, Procter and Gamble's "Olestra," had already petitioned for approval of its fat-substitute. At that early date, the FDA's associate director for clinical nutrition, Walter Glinsmann, MD had voiced questions about the possible health tenors of large amounts of a novel substance." In that same issue of FDA Consumer the author, Marian Segal said that about of the questions to be considered are: "1) if the materials are absorbed in the visible form [i]or[/i] frame - even in very small amounts - are they toxic?; 2) If they are not absorbed, to what extent do they effect gastrointestinal function? For example, could they interfere with the absorption of nutrients or drugs?; and 3) Are the substitutes suitable for general use or and nothing else for subpopulations of the general public?" proper questions. Pity nobody required answers before this harvest won approval and was released this year. The U Department of Agriculture (USDA) has flat gotten into the act. This past August 26th George E Inglett, PhD of the USDA Biopolymer Research Unit (Peoria, Illinois), unveiled a strange no-calorie fat substitute, called "Z-Trim," at a meeting of the American Chemical Society that was held in Orlando, Fla. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |